Citation: Ak. Ganguly et al., Farnesyl protein transferase inhibition: A novel approach to anti-tumor therapy. The discovery and development of SCH 66336, CURR MED CH, 8(12), 2001, pp. 1419-1436
Authors:
Ashar, HR
James, L
Gray, K
Carr, D
McGuirk, M
Maxwell, E
Black, S
Armstrong, L
Doll, RJ
Taveras, AG
Bishop, WR
Kirschmeier, P
Citation: Hr. Ashar et al., The farnesyl transferase inhibitor SCH 66336 induces a G(2) -> M or G(1) pause in sensitive human tumor cell lines, EXP CELL RE, 262(1), 2001, pp. 17-27
Authors:
Bishop, WR
Pai, JJK
Armstrong, L
Dalton, MB
Doll, RJ
Taveras, A
Njoroge, G
Sinensky, M
Zhang, F
Liu, M
Kirschmeier, P
Citation: Wr. Bishop et al., Tricyclic farnesyl protein transferase inhibitors - Antitumor activity andeffects on protein prenylation, CANC DRUG, 8, 2001, pp. 87-101
Authors:
Njoroge, FG
Vibulbhan, B
Wong, JK
White, SK
Wong, SC
Carruthers, NI
Kaminski, JJ
Doll, RJ
Girijavallabhan, V
Ganguly, AK
Citation: Fg. Njoroge et al., Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors offarnesyl protein transferase, ORG LETT, 1(9), 1999, pp. 1371-1373
Authors:
Njoroge, FG
Vibulbhan, B
Bishop, WR
Kirschmeier, P
Bryant, MS
Nomeir, AA
Liu, M
Doll, RJ
Girijavallabhan, VM
Ganguly, AK
Citation: Fg. Njoroge et al., Atropisomeric trihalobenzocycloheptapyridine analogues provide stereoselective FPT inhibitors with antitumor activity, BIO MED CH, 7(5), 1999, pp. 861-867
Authors:
Liu, M
Bryant, MS
Chen, JP
Lee, SN
Yaremko, B
Li, ZJ
Dell, J
Lipari, P
Malkowski, M
Prioli, N
Rossman, RR
Korfmacher, WA
Nomeir, AA
Lin, CC
Mallams, AK
Doll, RJ
Catino, JJ
Girijavallabhan, VM
Kirschmeier, P
Bishop, WR
Citation: M. Liu et al., Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice, CANC CHEMOT, 43(1), 1999, pp. 50-58
Authors:
Taveras, AG
Deskus, J
Chao, JP
Vaccaro, CJ
Njoroge, FG
Vibulbhan, B
Pinto, P
Remiszewski, S
del Rosario, J
Doll, RJ
Alvarez, C
Lalwani, T
Mallams, AK
Rossman, RR
Afonso, A
Girijavallabhan, VM
Ganguly, AK
Pramanik, B
Heimark, L
Bishop, WR
Wang, L
Kirschmeier, P
James, L
Carr, D
Patton, R
Bryant, MS
Nomeir, AA
Liu, M
Citation: Ag. Taveras et al., Identification of pharmacokinetically stable 3,10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities, J MED CHEM, 42(14), 1999, pp. 2651-2661
Authors:
Strickland, CL
Weber, PC
Windsor, WT
Wu, Z
Le, HV
Albanese, MM
Alvarez, CS
Cesarz, D
del Rosario, J
Deskus, J
Mallams, AK
Njoroge, FG
Piwinski, JJ
Remiszewski, S
Rossman, RR
Taveras, AG
Vibulbhan, B
Doll, RJ
Girijavallabhan, VM
Ganguly, AK
Citation: Cl. Strickland et al., Tricyclic farnesyl protein transferase inhibitors: Crystallographic and calorimetric studies of structure-activity relationships, J MED CHEM, 42(12), 1999, pp. 2125-2135